European Heart Journal

Article	Citations
SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players	8506
Long-term follow-up of early leaflet thrombosis after transcatheter aortic valve replacement	4043
Associations between changing patterns of ST-T waves morphologies in rest electrocardiography and cardiovascular risk in an asymptomatic low risk population: a report from Ansan-Ansung cohort study	3533
Lipid testing trends before and after hospitalization for myocardial infarction among adults in the U.S., 2008–2019	2141
Prognostic value of cardiac magnetic resonance in elderly patients soon after ST-segment elevation myocardial infarction	2025
Influence of diabetes, heart failure, and NT-proBNP on cardiovascular outcomes in patients with atrial fibrillation – insights from a cohort study of 7,412 patients with extended follow-up	1640
The role of bystander-initiated basic life support in exercise-related sudden cardiac arrest: a systematic review	1522
Comparison of valve durability among different transcatheter and surgical aortic valve prostheses: a network meta-analysis	1292
Left main coronary artery dimension and variation in Thai population	1143
Protective effects of dapagliflozin on vascular remodeling in the carotid artery following balloon injury – potential role of angiotensin and purinergic signaling	1042
Leukocyte telomerase concentration is inversely associated with central wave reflection in patients with hypertension	893
The bimodal rise and fall acute coronary syndromes curves paralleling COVID-19 outbreaks	770
Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study	715
Clinical characteristics and natural history of pre-adolescent non-syndromic hypertrophic cardiomyopathy	700
Cardiac reparative therapy with adipose graft transposition procedure (AGTP) improves electrophysiological remodeling of chronic myocardial infarction	696
The impact of diabetes mellitus on carotid atherosclerosis and arterial stiffness; results from the Corinthia study	666
Percutaneous coronary intervention in patients with peripheral artery disease and adverse cardiovascular adverse event and bleeding	636
Percutaneous bioprosthetic aortic valve durability: results a single center after ten years of follow-up ago	635
Human pericardial fluid exosomes regulate macrophage immunophenotype: new prospective for cardiovascular myocardium-epicardium crosstalk in coronary artery disease	567
Speckle tracking-derived left atrial stiffness predicts adverse events after successful electrical cardioversion	535
Initial combination therapy for hypertension in patients of African ancestry: a systematic review and meta-analysis	470
Cohort of patients with hypertrophic cardiomyopathy and alpha tropomyosin 1 variants followed up at a national reference center	453
Coronary perforations and its clinical impact during CTO recanalization: a 2054 patients pooled analysis from the Latin American (LATAM) CTO registry	424
Impact of left heart disease risk factors on risk stratification and treatment response in pulmonary arterial hypertension	379
Staging cardiac damage in aortic valve disease: one size fits all?	374

Gender bias in ACS management	343
Concomitant real-time measurement and correlation of contact force to baseline local impedance and local impedance drops in RF ablation of left and right atrial procedures	316
Impact of catheter ablation on functional tricuspid regurgitation in patients with atrial fibrillation	308
Blood pressure response during treadmill exercise testing and the risk for future cardiovascular events and new-onset hypertension	288
TAPSE or right-to-lleft ventricle diameter ratio at echocardiography to predict death in patients with acute pulmonary embolism: a meta-analysis	276
The effect of prolonged Intraaortic ballon pump (IABP) support on right ventricular function in end-stage heart failure	271
Comparison of mortality prediction scores in elderly patients with ICD for heart failure with reduced ejection fraction	224
Pericardiocentesis over 3 years at a tertiary referral Australian hospital	223
Left atrial strain evaluation and prognostic value in constrictive pericarditis patients undergoing pericardiectomy	220
Exploring the cross-talk between liver and vessels through increased morning blood pressure in hypertension	212
Correction to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary sy	211
Characteristics of warfarin underprescription in older adults with atrial fibrillation	209
Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy	207
Correlation of Seattle Angina Questionnaire score and post-procedural outcomes in patients undergoing multi-vessel coronary intervention	206
Wild-type transthyretin cardiac amyloidosis: the need for a comprehensive geriatric assessment beyond age	200
Induction of RAGE-NFkB signalling axis enhances SHP-2 tyrosine phosphatase expression resulting in deviant activation of diabetic monocytes	191
Dynamic optimization of CRT pacing using a novel algorithm improves survival in a real-world cohort of patients	190
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis	184
Impact of left atrial strain assessed with feature-tracking computed tomography on long-term mortality after transcatheter aortic valve implantation	180
Percutaneous transluminal angioplasty associated with a comparable risk of mortality in old patients with severe lower extremities arterial disease	178
Validity and utility of the questionnaire-based FRAIL scale in elderly patients with heart failure: findings from the FRAGILE-HF	172
Leadless pacemaker implant in the elderly: a safe and feasible solution	172
Use of sirolimus-coated balloon in de novo small vessel coronary lesions; Long-term follow-up from a single centre registry	170
Adherence to guidelines of diagnostic and therapeutic practices for suspected infections of cardiac implantable electronic devices	165
Two types of humoral response in acute myocardial infraction	151
Protective effects of different types of bariatric surgeries on myocardial ischemia-reperfusion injury in non-obese non-diabetic rats	148
Long-term outcomes in patients with left bundle branch block after transcatheter aortic valve replacement	147
Myocardial performance is impaired in cardiac amyloidosis: role of myocardial work-derived parameter in differential diagnosis with phenocopies and prognostic implications	145
Pregnancy in women with hypertrophic cardiomyopathy: observational data from the tertiary referral center registry	144
Interaction of inherited genetic variants in the NLRP3 inflammasome/IL-6 pathway with acquired clonal hematopoiesis to modulate mortality risk in patients with HFrEF	144
Simulating atrial fibrillation patterns and screening strategies using virtual patient-level models	142
Stroke volume but not ejection fraction predicts prognosis in acute heart failure	142
Real-world performance of a fully automatic antitachycardia pacing algorithm	141
Prognosis of diastolic dysfunction in patients with preserved LVEF. Value of left atrial strain	139
Atrial fibrillation organisation correlates with ventricular response regularity in patients with persistent atrial fibrillation	137
Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study	136
Subclavian versus axillary vein puncture for implantation of cardiac electronic devices. A meta-analysis	135
Heart failure with reduced ejection fraction: predicting exercise intolerance with echocardiography	135
Impact of a 12-week supervised exercise program on weight loss trajectory, daily physical activity levels and sedentary behaviors after bariatric surgery	135
Effect of antimicrobial therapy on the embolic events in patients with infective endocarditis	134
A variant noncoding region regulates Prrx1 and predisposes to atrial arrhythmias	131
Association between plasma desmosine, a marker of elastin degradation, and total atherosclerotic burden measured by whole body magnetic resonance angiography	130
Absence of exercise capacity improvement after in-hospital short-term cardiac rehabilitation is associated with long-term clinical outcome in heart failure patients	129
Less dementia in patients with newly diagnosed atrial fibrillation adhering with a clustering of healthy lifestyle behaviours: a nationwide population-based cohort study	129
Safety and efficacy of cerebral embolic protection devices in transcatheter aortic valve implantation: a meta-analysis	128
Global burden of metabolic diseases: data from Global Burden of Disease 2000-2019. A cosortium of metabolic disease	123
Trends in infective endocarditis mortality in the United Kingdom and EU 15+ countries between 1990–2019: an analysis of the Global Burden of Diseases database	120
Corrigendum to: Backup natural pacemaker found in the heart	119
Protective effects of renal denervation based on MRI assessment of the brain in patients with resistant hypertension	118
Predictive value of the left ventricular function in coronary artery disease: should we tailor risk-stratification for men and women?	118

Secondary prevention of cerebrovascular events in patients with “asymptomatic” atherosclerotic stenosis of the vertebral arteries	116
Cumulative prognostic effect of diabetes and myocardial injury in patients attended in the emergency room	116
Elevated markers of liver function are associated with poorer outcomes in HFREF: an analysis of DAPA-HF	116
Eisenmenger syndrome: is it the same entity in adulthood and pediatric age?	115
Feasibility of remote support for electrophysiological ablation procedures during CoVid-19 pandemics	115
Prediction of early left ventricular recovery and adverse remodelling in patients with acute myocardial infarction: the role of non-invasive myocardial work evaluation	115
The impact of non-pharmacological therapies on cardiovascular outcomes in patients with refractory angina: a systematic review and meta-analysis of randomized controlled trials	113
Peripheral vascular involvement in transthyretin cardiac amyloidosis. A comparative analysis with AL amyloidosis	113
Effect of LPA gene on CAD risk among diabetic patients	112
Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis	110
Allied health professional-physician collaboration to enhance guideline-directed medical therapy of heart failure: expanding therapeutic opportunities	110
Impact of COVID-19 pandemics on the incidence and mortality in Takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry	110
Beta-blockers after STEMI: prognostic impact and predictors of adherence, results from the real-world FAST-STEMI registry	109
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study	109
The expression of selected microRNAs enables identification of patients with functional atrial tricuspid regurgitation. New insights into TR pathophysiology	109
Acute infections and inflammatory biomarkers in patients with acute pulmonary embolism	108
Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis	107
Artificial intelligence-assisted examination of cardiac health status through electrocardiogram	107
Clinical profile and incidence of 36-month cardiovascular events in patients with MINOCA: a regional registry of 126 patients in a tertiary cardiology hospital	106
Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease	105
Associations of maternal exposure to multiple plasma metals with the risk of fetal congenital heart defects: a prospective nested case-control study	104
Pulmonary artery aneurysm in pulmonary arterial hypertension associated with congenital heart disease	104
Microtransesophageal echocardiographic guidance of patent foramen ovale percutaneous closure	103
Amiodarone and the risk for pulmonary fibrosis. A Danish nationwide study	103
Coronary rotational atherectomy in patients with severe aortic stenosis	102
Cumulative accelerometer-based sedentary time from childhood through young adulthood with progressive left ventricular remodelling in British youth: a 13-year longitudinal study	102
Reporting quality of randomized controlled trials of percutaneous patent foramen ovale closure for the treatment of migraine based on the CONSORT statement	101
Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation	101
Outcomes of chronic total occlussion recanalization in patients with prior bypass-surgery: an updated systematic review and meta-analysis of real world registries	101
Estimation of antihypertensive effect after initiating continuous positive airway pressure treatment in Japanese patients with sleep disordered breathing	101
Feasibility and efficacy of a novel 6 french sheathless guiding catheter equipped with peel-off type external dilator for PCI with distal radial approach - a Japanese multicenter study	101
Efficacy of intravascular lithotripsy (IVL) in coronary stenosis with severe calcification: a systematic review and meta-analysis of 38 studies	100
Reducing the burden of inconclusive smart-device single-lead ECG tracings via a novel atificial intelligence algorithm	99
Moderate mixed aortic valve disease -evaluation, treatment and prognosis of patients referred to heart valve center	99
Cardiac troponin T and I are differentially associated with myocardial fibrosis assessed by cardiac magnetic resonance imaging	98
Associated factors and clinical implications of dynamic changes in late gadolinium enhancement after acute myocarditis	98
Myocardial performance index improves prediction of major adverse cardiovascular events and heart failure in type 1 and type 2 diabetes without known heart disease: Thousand&1 and Thousand&2 s	98
Spin-lock based magnetic field sensing: a non-invasive MRI method for spatially resolved imaging of cardiac conduction?	97
Machine learning using cardiovascular magnetic resonance to predict cardiovascular events in patients with acute myocarditis	97
Left ventricular early diastolic strain rate and cardiovascular outcome in patients with left ventricular non-compaction phenotype	96
MINOCA due to vasospasm compared to other mechanisms: patients characteristics, evolution and prognosis	95
Management of hospital resources for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) - an approach to deescalate ?	94
Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in CFA-challenged albino mice	92
Agreement between two independent raters in identifying exercise oscillatory ventilation in patients with heart failure	92
Age differences in the association between arterial velocity pulse index and muscle sympathetic nerve activity in hypertensive patients	91
Contrast-induced nephropathy after staged balloon pulmonary angioplasty: lower risk compared with left-sided cardiac procedures	90
Abnormal left-sided blood volume, wall shear stress & energy loss in patients with repaired Tetralogy of Fallot identified by 4D flow MRI	89
Emotional and cardiovascular health: the impact of depression on cardiac autonomic activity	89
Coronary lesions suggestive of kawasaki disease in young patients presenting with acute myocardial infarction	88
Genome-wide association study of atrial fibrillation in 114,539 Finnish individuals reveals novel locus associated with cardiac remodelling	88
His bundle pacing: safety, performance, and clinical outcomes in a single centre experience	88
Effect of risk enhancers versus technical aspects of high thrombotic risk criteria on adverse clinical events after PCI: insights from 2020 ESC NSTE-ACS Guidelines	87
Beta-blocker could show the prognostic impact in heart failure patients even on the regular hemodialysis	87
Association of Body mass index and clinical outcomes in patient with coronary artery disease undergoing percutaneous coronary intervention	84
Vericiguat: a QTc interval study in patients with coronary artery disease	83
Uncontrolled diabetes predicts anxiety and depression in CAD patients	82
Endocardial pacing compared to epicardial left ventricle pacing and right ventricle pacing: a single center long term experience in a pediatric population	82
Leuko-platelet index as an independent predictor of in-hospital events in patients with non-ST elevation acute coronary syndrome	81
Ventricular-arterial coupling changes as an early predictor of left ventricular remodelling in atrial fibrillation	81
Hypolipidemia associated with inactivation of TM6SF2 is due to decreased VLDL-lipids secretion	81
Impact of cumulative burden of body mass index and waist circumference on risk of atrial fibrillation: an analysis of 3,700,000 participants who underwent 4-year consecutive annual health examination	81
An association of low-density lipoproteins and fibrinolysis in patients with severe aortic stenosis- valvular expression of fibrinolytic proteins	80
The impact of mitral regurgitation grade on exercise capacity following cardiac rehabilitation program after transcatheter aortic valve implantation	80
Outcomes of patients with high bleeding risks characteristics presenting with acute coronary syndrome undergoing percutaneous coronary intervention	80
Cardiac complications as a major predictor of in-hospital death in infective endocarditis using machine-learning algorithm analysis	79
Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation	79
Residual leaks after transcatheter left atrial appendage closure: why and how to assess it?	79
Intricacies of aortic risk assessment studies: not a simple matter	79
Pulmonary haemodynamics and pulmonary congestion: where are we now?	78
The Antwerp score: is this the ‘new hope on the horizon’?	77
Female representation on editorial boards of the National Societies of Cardiology Journals of the European Society of Cardiology	77
Reflections on Hypertrophic Cardiomyopathy	77
A newly designed glucagon-like peptide-1 receptor agonist reduces cardiovascular and renal events in high-risk type 2 diabetes	77
A rare case of a dorsal mass caused by descending thoracic aortic dissection	76
Outcomes of extracorporeal membrane oxygenation with or without left ventricular unloading devices in patients with non-myocardial infarction cardiogenic shock	75
Does transition through menopause affect cardiovascular disease risk factors? Results from a population-based cohort (CoLaus study)	75
New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies	75
Location and impact of the infarct-related artery in acute coronary syndrome: insight from the Swiss SPUM- ACS cohort	74
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled	74
Ablation therapies for paroxysmal atrial fibrillation: a systematic review and patient-level network meta-analysis	74

Meet the European Society of Cardiology Gold Medallists 2022	74
Figuring out complete left ventricular reverse remodeling in tachycardiomyopathy	73
Reduced 3D-left atrium ejection fraction predicts development of atrial fibrillation in patients with hypertrophic cardiomyopathy	73
Sympathetic nerve activity changes following acute exposures to electronic and tobacco cigarette smoking in humans	73
Sequential left ventricular electro-mechanical changes in left bundle branch pacing vs right ventricular pacing a two-center study	73
Characteristics and long-term ablation outcomes of supraventricular arrhythmias in hypertrophic cardiomyopathy: a 10-year, single-center experience	73
Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle	73
Microvascular dysfunction and absolute coronary blood flow after percutaneous coronary intervention of a chronic total occlusion	73
Early Intervention with Impedance-guided Heart Failure Management Improves Long-term Outcome: insights From the IMPEDANCE-HF Trial	72
Right ventricular free wall longitudinal strain (RVFWSL) a new outcome predictor in patients candiate for TAVI	72
Heart failure therapy in new onset heart failure versus chronic heart failure: an analysis of 90,383 patients from the Swedish Heart Failure Registry (SwedeHF)	72
Early diastolic strain rate and its associations with estimated glomerular filtration rate and albuminuria	72
Targeting Neurofibromin 2 (NF2) prevents endothelial dysfunction in obesity: a study in mice and humans	72
Prognostic impact of echocardiographic derived precapillary wedge pressure and pulmonary vascular resistances in patients with heart failure	71
ARNI effects in HFrEF. Risk reduction beyond LVEF	70
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors	70
Differential efficacy and safety of oral anticoagulation in atrial fibrillation patients with or without comorbid vascular disease: insights from the GARFIELD-AF registry	69
Progression, regression and redefining the treatment response – cardiac magnetic resonance with T1 and extracellular volume mapping in cardiac light-chain amyloidosis	68
Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation	68
Sacubitril-valsartan activates pAMPK and reduces NLRP3, MyD88, cytokines/growth factors and DAMPs in doxorubicin-treated mice improving longitudinal strain and ejection fraction	68
Real-time electrophysiological characterization of acute and chronic radiofrequency ablation lesions	68
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?	68
Morphology-Voltage-P-wave duration (MVP) score in prediction of incident atrial fibrillation in an elderly epidemiologic cohort	67
Influence of lead extraction on tricuspid valve function	67
Epicardial adipose tissue volume and density is associated with cardiac dysfunction in asymptomatic people with type 2 diabetes	67
Routine use of 3-dimensional zoom modality with 2-dimensional transesophageal echocardiography to decide the candidacy for transcatheter device closure of atrial septal defect	67
Further prognostic stratification in patients with oscillatory ventilation with exercise: is there more to it than just ups and downs?	67
Influence of radiotherapy on cardiac implantable device lead parameters	67
Various arrhythmia types and their day-by-day occurrence rates over a 14-day period using a P-wave sensitive ambulatory ECG monitored population	67
Acute and long-term success of left atrial anterior line and mitral isthmus line ablation in patients after mitral valve surgery	66
Phenotyping of heart failure with preserved ejection faction using health electronic records and echocardiography	65
Temporal trends in infection-related hospitalizations in patients with heart failure: a nationwide study from 1997 to 2017	65
Mortality and predictors of death in women and men with congestive heart failure of different types of cardiomyopathies	65
Ten year survival after an acute heart failure episode	65
Strategic management to optimize response to cardiac resynchronization therapy registry	64
Variations in atrial fibrillation screening after ischemic stroke or transient ischemic attack in Sweden	64
Bipolar ablation of refractory ventricular arrhythmias using a novel dedicated adapter. A multicenter study	64
Primary care screening and prevention of heart failure coordinated by cardiologist in rural areas	63
Results from a nationwide atrial fibrillation screening effort in Belgium	63
Ten years survival benefit of CABG or PCI based on individual prediction	63
Real-world data from the use of ranolazine in patients with stable angina pectoris: the RANGER study	63
Efficacy of controlvit as a complementary strategy in reducing hospitalizations in patients with heart failure. Randomized clinical trial	63
Combined cardiopulmonary test and exercise Doppler echocardiography in systemic sclerosis	63
Acute heart failure after non-cardiac surgery: incidence, phenotypes, determinants and outcomes	63
COVID-19 vaccination in the pediatric age and risk for myocarditis	62
Strengthening cardiovascular trials across Australia and New Zealand—the Alliance for Cardiovascular Trials (ANZACT) Network	62
NOAC in adult congenital heart disease patients: a single-center experience	62
Application of the 2019 ESC/EAS dyslipidemia guidelines to a Mexican population: evaluating treatment targets for secondary prevention in clinical practice	62
Atherogenic lipoprotein profile associated with anthropometric indices of obesity and their association with cardiometabolic risk markers: a cross-sectional study in community	62
The extended role of 24 h ambulatory blood pressure monitoring for reflex syncope	61
Unmeasured confounding is always unnerving: cannabis and cardiovascular risk	61
Do we need new thresholds for surgical repair in patients with ascending thoracic aortic aneurysm disease?	61
Additional value of 18fluorodeoxyglucose positron emission tomography/computed tomography combined with intracardiac echocardiography to detect lead vegetations	61
Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project	61
One-shot thrombolysis for the management of acute ischaemic stroke	61
The COVID-19 pandemic and heart failure: lessons from GUIDE-HF	61
Obituary Joep Perk	61
Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure	60
Immortal Time Bias: the hidden confounder in assessing cardiosurgical treatment effects	60
Stress echocardiography: the quest for risk stratification beyond myocardial ischaemia	60
When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease	60
Reconsidering safety and reducing barriers to MRI in patients with cardiac implantable electronic devices	60
Follow-up on new marker confirming the optimal status in the treatment of heart failure with reduced ejection fraction	60
A case of crowded heart: closing the door after the visitors	60
Doubly committed ventricular septal defect closure using an eccentric occluder via minimal incision in the anterior median sternum through the left parasternal third intercostal space	59
Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best	59
High plasma levels of soluble LOX-1 portends poor survival in acute coronary syndromes beyond GRACE 2.0: a multicentre prospective cohort study	58
Validation of HAS-BELD scoring system and risk factors of bleeding with warfarin among non-valvular atrial fibrillation patients	58
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?	58
Impact of diabetes mellitus on long-term survival after transcatheter mitral valve edge-to-edge repair	58
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction	57
Diffusion tensor imaging to assess myocardial microstructure after infarction by magnetic resonance	57
Dissecting the effect of genetic variants on atherosclerosis: integrating bulk and single-cell transcriptomics	57
Do health care physician need to risk their own lives? Time to change our own attitude towards recommended physical activity	57
Increased right amygdala activity during the hyper-acute phase of takotsubo syndrome	57
Behavioral economics strategies for promoting adherence to treatment in heart failure patients	57
12-month post-trial follow-up of participants in the Australian arm of the second low-dose colchicine trial	56
Therapeutic components of an automated digital counselling intervention for chronic heart failure	56
Disease trajectories following myocardial infarction: insights from process mining of 145 million hospitalisation episodes	56
Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry	56
Management and clinical outcome of patients with atrial fibrillation stratified by the 4S-AF scheme for structured characterization of atrial fibrillation: data from CODE-AF registry	56
The role of process mining tools in STEMI networks: where should we build a new primary PCI centre?	56
Heavy weekly alcohol consumption versus binge drinking after an acute coronary syndrome and risk of major adverse cardiovascular events at one year follow up	55
Cardioprotective effect of empagliflozin in acute myocardial infarction: the role of ketone bodies availability	55
Hemodynamic pulmonary response to exercise according to different resting pulmonary hypertension thresholds in chronic thromboembolic pulmonary disease	55
Artificial intelligence as a precision tool for predicting risk of in-hospital death after aortic valve replacement	55
24h SCAI stage reclassification to predict outcome. Insights from the prospective Altshock-2 registry	55
Ischemic stroke in patients with congenital heart disease and atrial fibrillation	55
New definition of hypotension in patients with reflex syncope using 24-hour ambulatory blood pressure monitoring (SynABPM Study)	55
Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS	55
AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 2*1*2 knock-in mice	54
Early quantitative pupillary response parameters have high predictive value for 30-day mortality in patients resuscitated from out-of-hospital cardiac arrest	54
Machine learning can accurately detect abnormal aortic valves in CMR	54
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction	54
Optimal CW-Doppler derived parameter for the diagnosis of iatrogenic mitral stenosis during transcatheter edge-to-edge repair for mitral regurgitation	54